EpiVax Therapeutics
Richard Lipkin is a Managing Director of Easton. Previously, he was a partner of Commerce Health Ventures, a life sciences healthcare fund, and Laird & Co., a private merchant bank; a biotech analyst consultant for a Goldman Sachs hedge fund and for DARPA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
EpiVax Therapeutics
EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.